Teva Pharmaceutical Industries Beats By a Penny, Revenue up 25% (TEVA) - Zibb.com

Zibb.com | Nov 3, 2009

11/3/2009 - Teva Pharmaceutical Industries (NASDAQ:TEVA) reported Q3 EPS of $0.89, ex-items, beating consensus analyst estimates of $0.88. Revenue for the quarter rose 24.9% year-over-year to $3.55 billion, falling short of consensus estimates of $3.63 billion. President and CEO Shlomo Yanai said,...

Permalink

Teva to Report Third Quarter 2009 Financial Results on November 3, 2009 - Zibb.com

Zibb.com | Oct 15, 2009

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its third quarter 2009 financial results on Tuesday, November 3, 2009. Teva will host a conference call and live webcast on the same day, at 8:30 a.m. ET to discuss its third quarter 2009 results and overall...

Permalink

Teva Pharmaceutical Industries Ltd.(ADR) (TEVA) Corporate Event A...

Zibb.com | Oct 14, 2009

Teva Pharmaceutical Industries Ltd.(ADR) (TEVA) Expected next earnings release: Announcement date: 11/3/2009 - Before Market Earnings Quarter: Q3 Announcement Status: Unconfirmed Expected next dividend: Dividend Announcement Date: 7/28/2009 Dividend Record Date: 8/5/2009 Dividend Pay Date:...

Permalink

Teva Announces Presentations at Bank Conferences - Zibb.com

JERUSALEM, Sep 11, 2009 (BUSINESS WIRE) --

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Morgan Stanley Global Healthcare Conference in New York with William Marth, President and Chief Executive Officer, Teva North America presenting on Monday, September 14, 2009. Eyal Desheh, Chief Financial Officer & Gerard van Odjik, President and CEO, Teva Europe will present on Tuesday, September 15, 2009 in London at the Bank of America Merrill Lynch Global Healthcare Conference.

What:   Teva Presentation at the Morgan Stanley Global Healthcare Conference           Teva Presentation at the Bank of America Merrill Lynch Global
                                                                                       Healthcare Conference
Who:    William Marth, President and Chief Executive Officer, Teva North               Eyal Desheh, Chief Financial Officer
        America                                                                        Gerard van Odjik,
                                                                                       President & CEO, Teva Europe
When:   Monday, September 14, 2009 at 9:45 a.m. ET                                     Tuesday, September 15, 2009 at 1:00 p.m. UKT / 8:00 a.m. ET
Where:  http://www.tevapharm.com/financial/                                            http://www.tevapharm.com/financial/
        or                                                                             or
        http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TEVA&item_id=2400624  http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=TEVA&item_id=2423787
How:    Live over the Internet -- log on to the Web at the address above and
        register for the event (approx. 10 minutes before). An archive of
        the webcast will be available on Teva's website.

Teva Pharmaceutical Industries Ltd. 
Elana Holzman, 972 (3) 926-7554 
or 
Teva North America 
Kevin Mannix, 215-591-8912 
www.tevapharm.com

Read more...

Tags: animal   bank   ceo   conference   europe   health   healthcare   israel   london   manufacturer   nasdaq   north america   pharmaceuticals   president   products   sales  

Companies: Morgan Stanley (MS), Teva Pharmaceutical Industries, Ltd (TEVA)

Permalink